Literature DB >> 27534811

A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets.

Qianghua Hu1, Min Soon Cho1, Perumal Thiagarajan2, Fleur M Aung3, Anil K Sood4, Vahid Afshar-Kharghan1.   

Abstract

Cyclooxygenase (COX) is the rate-limiting enzyme in conversion of arachidonic acid to prostanoids, and has two isoforms, COX1 and COX2, which share ~65% amino acid homology. COX1 is universally expressed in many cell types including platelets; however, expression of COX2 is known to be more limited. We examined expression of COX2 mRNA and protein in platelets and platelet-derived microparticles (MPs); using quantitative RT-PCR, immunostaining, and Western blotting. We have detected a significant amount of COX2 in platelets, both at mRNA and protein levels. We found that COX1/COX2 mRNA and protein ratios in platelets were 370:1 and 17:1, respectively. Expression level of COX2 in platelets was less than COX1, but comparable to the expression of COX2 in malignant epithelial cells. Considering the important role of COX2 in tumorigenesis and thrombosis, and the large number of circulating platelets, we propose that platelet COX2 may play an important role in physiologic and pathologic conditions.

Entities:  

Keywords:  COX1COX2; COX2; Platelets; expression

Mesh:

Substances:

Year:  2016        PMID: 27534811      PMCID: PMC5310196          DOI: 10.1080/09537104.2016.1203406

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  17 in total

Review 1.  Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

Authors:  Daniel L Simmons; Regina M Botting; Timothy Hla
Journal:  Pharmacol Rev       Date:  2004-09       Impact factor: 25.468

2.  Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice.

Authors:  Silvia S Barbieri; Giovanna Petrucci; Eva Tarantino; Patrizia Amadio; Bianca Rocca; Maurizio Pesce; Kellie R Machlus; Franco O Ranelletti; Sara Gianellini; Babette Weksler; Joseph E Italiano; Elena Tremoli
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

3.  Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.

Authors:  Elena I Sinauridze; Dmitry A Kireev; Nadezhda Y Popenko; Aleksei V Pichugin; Mikhail A Panteleev; Olga V Krymskaya; Fazoil I Ataullakhanov
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

4.  Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.

Authors:  Wan-Lin Yang; Isabelle H Roland; Andrew K Godwin; Xiang-Xi Xu
Journal:  Oncogene       Date:  2005-12-01       Impact factor: 9.867

Review 5.  Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials.

Authors:  Luis A Garcia Rodriguez; Lucia Cea-Soriano; Stefania Tacconelli; Paola Patrignani
Journal:  Recent Results Cancer Res       Date:  2013

6.  Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets.

Authors:  Bianca Rocca; Paola Secchiero; Giovanni Ciabattoni; Franco O Ranelletti; Lucia Catani; Lia Guidotti; Elisabetta Melloni; Nicola Maggiano; Giorgio Zauli; Carlo Patrono
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 7.  Cyclooxygenases: structural and functional insights.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  J Lipid Res       Date:  2008-10-23       Impact factor: 5.922

8.  Platelets increase the proliferation of ovarian cancer cells.

Authors:  Min Soon Cho; Justin Bottsford-Miller; Hernan G Vasquez; Rebecca Stone; Behrouz Zand; Michael H Kroll; Anil K Sood; Vahid Afshar-Kharghan
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

9.  Lactadherin and clearance of platelet-derived microvesicles.

Authors:  Swapan K Dasgupta; Hanan Abdel-Monem; Polly Niravath; Anhquyen Le; Ricardo V Bellera; Kimberly Langlois; Shigekazu Nagata; Rolando E Rumbaut; Perumal Thiagarajan
Journal:  Blood       Date:  2008-11-20       Impact factor: 22.113

10.  Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.

Authors:  Viola Allaj; Changxiong Guo; Daotai Nie
Journal:  Cell Biosci       Date:  2013-02-06       Impact factor: 7.133

View more
  4 in total

1.  Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.

Authors:  Qianghua Hu; Takeshi Hisamatsu; Monika Haemmerle; Min Soon Cho; Sunila Pradeep; Rajesha Rupaimoole; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Stephen T C Wong; Anil K Sood; Vahid Afshar-Kharghan
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

Review 2.  Nets, pulmonary arterial hypertension, and thrombo-inflammation.

Authors:  Luís Pedro Baptista de Barros Ribeiro Dourado; Mário Santos; Daniel Moreira-Gonçalves
Journal:  J Mol Med (Berl)       Date:  2022-04-20       Impact factor: 4.599

3.  Inhibitory Mechanisms of Lusianthridin on Human Platelet Aggregation.

Authors:  Hla Nu Swe; Boonchoo Sritularak; Ponlapat Rojnuckarin; Rataya Luechapudiporn
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

Review 4.  Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.

Authors:  Argentina Ornelas; Niki Zacharias-Millward; David G Menter; Jennifer S Davis; Lenard Lichtenberger; David Hawke; Ernest Hawk; Eduardo Vilar; Pratip Bhattacharya; Steven Millward
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.